UBS downgrades MercadoLibre stock rating on investment cycle concerns By Investing.com

UBS cut MercadoLibre to Neutral from Buy and reduced its price target to $2,050 from $2,700, citing ongoing investment-cycle pressure on margins and limited near-term upside. The firm lowered 2026-30 earnings estimates by about 9% on average and expects profitability to recover only from 2027-28 onward. Despite strong fundamentals, including 50.7% gross margin and 39% trailing revenue growth, the stock appears fairly valued at 39x 2026 earnings and 27x 2027 earnings.

Analysis

The market is repricing MELI from a near-term “growth at any cost” story into a multi-year execution trade, and that matters because the next leg of upside now needs operating leverage rather than top-line momentum. The key second-order effect is competitive: lower shipping thresholds and heavier credit/cross-border investment can pressure not just MELI’s own margins, but also force regional peers and smaller merchants to absorb worse economics or lose share, extending the investment cycle across the ecosystem.

The setup is less about whether MELI is winning and more about how long investors will tolerate delayed monetization. If margin recovery is pushed to 2027-28, the stock becomes more sensitive to small changes in rate assumptions, credit losses, and Brazil/Argentina macro volatility; that creates a long-duration multiple risk even if revenue remains healthy. In other words, a modest earnings miss or softer take-rate can matter disproportionately because the valuation already discounts a lot of structural quality.

Consensus may be underestimating the reflexive downside from “early-stage cycle” language: management credibility can support the story for a while, but it also raises the bar for proof. The contrarian angle is that the current reset may be a better entry point for investors willing to look 12-18 months out, because MELI’s infrastructure is increasingly hard to replicate and could eventually produce an earnings inflection once the investment wave moderates.

The main catalyst path is not a single quarter, but a sequence: continued investment intensity, then evidence of stable credit performance and shipping economics, then only later margin expansion. A clean reversal would require management to slow capex/opex growth without sacrificing share, or to show that credit cards and logistics are scaling with lower incremental burn. Until then, the risk is not business breakdown; it is valuation compression from time decay.

Key Decisions for Investors

• Short-term: sell covered calls against MELI into any post-downgrade bounce; 1-3 month tenor works best if the stock stays range-bound while investors digest slower margin recovery. Target is harvesting premium while capping upside in a name with delayed re-rating.
• Medium-term: pair long AMZN / short MELI for 3-6 months if you want e-commerce/logistics exposure with less earnings-duration risk. The thesis is that AMZN can re-accelerate margin improvement sooner, while MELI remains trapped in capex and competitive reinvestment.
• If holding MELI, reduce gross exposure and wait for a 15-20% drawdown or a visible inflection in operating margin before re-adding. Risk/reward improves materially only when forward estimates stop drifting lower.
• For event-driven investors, buy MELI put spreads 2-4 months out on strength; use strikes roughly 10-15% below spot to express downside from multiple compression rather than a business collapse. This is the cleanest way to monetize the time-horizon mismatch.
• Contrarian long: initiate a small starter position in MELI only if subsequent quarters show credit-loss stabilization and shipping subsidy discipline, with a 12-18 month horizon. The reward is asymmetric if the market begins to price a 2027-28 earnings inflection before it appears in consensus.